Zhang, X., Luo, P., Jing, W., Zhou, H., Liang, C., & Tu, J. (2018). circSMAD2 inhibits the epithelial–mesenchymal transition by targeting miR-629 in hepatocellular carcinoma. Onco Targets Ther.

Zhang, Xianwei, Ping Luo, Wei Jing, Hu Zhou, Chunzi Liang, and Jiancheng Tu. "CircSMAD2 Inhibits the Epithelial–mesenchymal Transition By Targeting MiR-629 in Hepatocellular Carcinoma." Onco Targets Ther 2018.

Zhang, Xianwei, et al. "CircSMAD2 Inhibits the Epithelial–mesenchymal Transition By Targeting MiR-629 in Hepatocellular Carcinoma." Onco Targets Ther 2018.